American Journal of Obstetrics & Gynecology
Volume 197, Issue 5 , Pages 486.e1-486.e10 , November 2007

Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes

Presented at the Pediatric Academic Society Meeting, San Francisco, CA, May 1, 2006.

  • Sanjiv B. Amin, MD

      Affiliations

    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • Corresponding Author InformationReprints: Sanjiv B. Amin, MD, Assistant Professor of Pediatrics, Golisano Children’s Hospital at Strong, P.O. Box 651, 601 Elmwood Ave, Rochester, NY 14642
    • ,
  • Robert A. Sinkin, MD, MPH

      Affiliations

    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • ,
  • J. Christopher Glantz, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Received 8 January 2007 ,Revised 23 February 2007 ,Accepted 14 April 2007.

References 

  1. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol. 1974;44:787–792
  2. Niebyl JR, Blake DA, White RD, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 1980;136:1014–1019
  3. Van den Veyver IB, Moise KJ. Prostaglandin synthetase inhibitors in pregnancy. Obstet Gynecol Surv. 1993;48:493–502
  4. Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of premature labor (Effects on the fetal ductus arteriosus). N Engl J Med. 1988;319:327–331
  5. Moise KJ, Ou CN, Kirshon B, Cano LE, Rognerud C, Carpenter RJ. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol. 1990;162:549–554
  6. Dudley DK, Hardie MJ. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol. 1985;151:181–184
  7. Neu J, Wu-Wang CY. Eicosanoids in the developing gastrointestinal tract. Semin Perinatol. 1987;11:22–30
  8. Wallace JL, Cohen MM. Gastric mucosal protection with chronic mild restraint: role of endogenous prostaglandins. Am J Physiol. 1984;247(2 Pt 1):G127–G132
  9. Peskar BM. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim Biophys Acta. 1977;487:307–314
  10. Meyers RL, Alpan G, Lin E, Clyman RI. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res. 1991;29:569–574
  11. Gleason CA, Clyman RI, Heymann MA, Mauray F, Leake R, Roman C. Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs. Am J Physiol. 1988;254(1 Pt 2):F38–F44
  12. Leffler CW, Busija DW, Fletcher AM, Beasley DG, Hessler JR, Green RS. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res. 1985;19:1160–1164
  13. Friedman Z, Whitman V, Maisels MJ, Berman W, Marks KH, Vesell ES. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol. 1978;18:272–279
  14. Rudolph AM, Heymann MA. Hemodynamic changes induced by blockers of prostaglandin synthesis in the fetal lamb in utero. Adv Prostaglandin Thromboxane Res. 1978;4:231–237
  15. Moise KJ. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol. 1993;168:1350–1353
  16. Bustos R, Ballejo G, Giussi G, Rosas R, Isa JC. Inhibition of fetal lung maturation by indomethacin in pregnant rabbits. J Perinat Med. 1978;6:240–245
  17. Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr. 1994;124(5 Pt 1):782–788
  18. Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol. 1989;74:567–572
  19. Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol. 1991;78:1093–1097
  20. Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol. 1991;164:981–986discussion 986-8
  21. Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo-controlled trial. Br J Obstet Gynaecol. 1999;106:467–473
  22. Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol. 1986;155:747–749
  23. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329:1602–1607
  24. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics. 1998;102:E56
  25. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr. 2000;159:153–155
  26. Gerson A, Abbasi S, Johnson A, Kalchbrenner M, Ashmead G, Bolognese R. Safety and efficacy of long-term tocolysis with indomethacin. Am J Perinatol. 1990;7:71–74
  27. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol. 1994;170(1 Pt 1):102–106
  28. al-Alaiyan S, Seshia MM, Casiro OG. Neurodevelopmental outcome of infants exposed to indomethacin antenatally. J Perinat Med. 1996;24:405–411
  29. Gardner MO, Owen J, Skelly S, Hauth JC. Preterm delivery after indomethacin (A risk factor for neonatal complications?). J Reprod Med. 1996;41:903–906
  30. Iannucci TA, Besinger RE, Fisher SG, Gianopoulos JG, Tomich PG. Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol. 1996;175(4 Pt 1):1043–1046
  31. Souter D, Harding J, McCowan L, O’Donnell C, McLeay E, Baxendale H. Antenatal indomethacin—adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol. 1998;38:11–16
  32. Vermillion ST, Newman RB. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol. 1999;181(5 Pt 1):1083–1086
  33. Pietrantoni MWJ, Weeks J, Bridges S, Johnson I, Spinnato JA, Gall SA. Adverse neonatal outcomes following antenatal indomethacin use. Am J Obstet Gynecol. 1995;172:415
  34. Weintraub Z, Solovechick M, Reichman B, et al. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2001;85:F13–F17
  35. Abbasi S, Gerdes JS, Sehdev HM, Samimi SS, Ludmir J. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol. 2003;189:782–785
  36. Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol. 2005;25:336–340
  37. Baerts W, Fetter WP, Hop WC, Wallenburg HC, Spritzer R, Sauer PJ. Cerebral lesions in preterm infants after tocolytic indomethacin. Dev Med Child Neurol. 1990;32:910–918
  38. Murata Y, Itakura A, Matsuzawa K, Okumura A, Wakai K, Mizutani S. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev. 2005;27:17–21
  39. Suarez RD, Grobman WA, Parilla BV. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol. 2001;97:921–925
  40. Parilla BV, Grobman WA, Holtzman RB, Thomas HA, Dooley SL. Indomethacin tocolysis and risk of necrotizing enterocolitis. Obstet Gynecol. 2000;96:120–123
  41. Van Overmeire B, Slootmaekers V, De Loor J, et al. The addition of indomethacin to beta mimetics for tocolysis: any benefit for the neonate?. Eur J Obstet Gynecol Reprod Biol. 1998;77:41–45
  42. Friedman S, Flidel-Rimon O, Steinberg M, Shinwell ES. Indomethacin tocolysis and white matter injury in preterm infants. J Matern Fetal Neonatal Med. 2005;18:87–91
  43. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;CD001992
  44. Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol. 2005;106:173–179
  45. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. 2000;283:2008–2012
  46. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–534
  47. Petitti DB. Statistical methods in meta-analysis. In:  Petitti DB editors. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. 2nd ed. New York: Oxford University Press; 2000;p. 83
  48. Jacqz-Aigrain E, Guillonneau M, Boissinot C, Bavoux F, Hartmann JF, Blot P. [Maternal and neonatal effects of indomethacin administrated during pregnancy (Apropos of 18 cases]). Arch Fr Pediatr. 1993;50:307–312
  49. Nishikubo T, Takahashi Y, Nakagawa Y, et al. Renal impairment in very low birthweight infants following antenatal indomethacin administration. Acta Paediatr Jpn. 1994;36:202–206
  50. Butler-O’Hara M, D’Angio CT. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J Perinatol. 2002;22:541–546
  51. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol. 1990;76:689–692
  52. Vanhaesebrouck P, Thiery M, Leroy JG, et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr. 1988;113:738–743
  53. Salokorpi T, Eronen M, von Wendt L. Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. Neuropediatrics. 1996;27:174–177
  54. Vermillion ST, Landen CN. Prostaglandin inhibitors as tocolytic agents. Semin Perinatol. 2001;25:256–262
  55. Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23:278–285
  56. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection (Clinical aspects and role of the cytokines in diagnosis and pathophysiology). Clin Perinatol. 1995;22:281–342
  57. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34:5–12
  58. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23-to-32 week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803–808

 The study was performed as part of a clinical investigational training toward a master’s degree in clinical research and was funded by K-23 National Institutes of Health Grant DC 06229.Cite this article as: Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007;197:486.e1-486.e10.

PII: S0002-9378(07)00540-6

doi: 10.1016/j.ajog.2007.04.019

American Journal of Obstetrics & Gynecology
Volume 197, Issue 5 , Pages 486.e1-486.e10 , November 2007

Article Tools

* Image Usage & Resolution